SCHEMBL32670916

SCHEMBL32670916

COc1cc2c(cc1OC)C(=O)c1ccccc1CS2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.51
▸ KDM4E B2RXH2 6/20 0.51
▸ AKR1B1 P15121 1/20 0.50
▸ MAPK14 Q16539 1/20 0.47
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ MAPT P10636 9/20 0.45
▸ SMN1; SMN2 Q16637 6/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ ACHE P22303 1/20 0.45
▸ LMNA P02545 4/20 0.44
▸ CASP3 P42574 2/20 0.44
▸ SENP8 Q96LD8 2/20 0.44
▸ SENP7 Q9BQF6 2/20 0.44
▸ SENP6 Q9GZR1 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ GAA P10253 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31123632 0.82 KDM4E (0.44) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL11481280 0.81 MAPT (0.57) ALDH1A1KDM4EAKR1B1MAPK14MEN1
SCHEMBL31123564 0.79 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL31123622 0.79 ALDH1A1 (0.42) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL31123617 0.78 KDM4E (0.47) ALDH1A1KDM4EMAPK14MEN1KMT2A
SCHEMBL31123665 0.78 ALDH1A1 (0.41) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL31123615 0.78 KDM4E (0.41) ALDH1A1KDM4EMAPTACHEHTT
SCHEMBL11873711 0.76 ELANE (0.51) ALDH1A1KDM4EAKR1B1MAPK14MEN1
SCHEMBL86279 0.76 ACHE (0.59) ALDH1A1KDM4EAKR1B1MAPK14MEN1
SCHEMBL31123671 0.76 ACHE (0.59) ALDH1A1KDM4EAKR1B1MAPK14MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692092-A1 NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF Aliad Biopharma (KR) 2026-02-11 — — EP claimed
EP-4692092-A1 NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF Aliad Biopharma (KR) 2026-02-11 — — EP disclosed
Send feedback